- All sections
- C - Chemistry; metallurgy
- C07H - Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids
- C07H 19/16 - Purine radicals
Patent holdings for IPC class C07H 19/16
Total number of patents in this class: 796
10-year publication summary
65
|
82
|
67
|
72
|
75
|
83
|
60
|
61
|
41
|
9
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Atea Pharmaceuticals, Inc. | 65 |
24 |
Illumina Cambridge Limited | 678 |
19 |
Janssen Biopharma, Inc. | 52 |
16 |
Epizyme, Inc. | 383 |
15 |
Gilead Sciences, Inc. | 1879 |
15 |
Idenix Pharmaceuticals LLC | 66 |
13 |
Centre National de La Recherche Scientifique | 9632 |
12 |
The Trustees of Columbia University in the City of New York | 3440 |
12 |
Emory University | 1498 |
11 |
Osaka University | 3143 |
11 |
Dana-Farber Cancer Institute, Inc. | 2455 |
10 |
The Scripps Research Institute | 1364 |
10 |
Roche Innovation Center Copenhagen A/S | 148 |
10 |
Merck Sharp & Dohme Corp. | 2247 |
9 |
Alios BioPharma, Inc. | 69 |
9 |
Arcus Biosciences, Inc. | 107 |
9 |
Janssen Pharmaceutica N.V. | 3839 |
8 |
Geron Corporation | 169 |
8 |
Idenix Pharmaceuticals, Inc. | 50 |
8 |
Ionis Pharmaceuticals, Inc. | 776 |
8 |
Other owners | 559 |